as 02-21-2025 4:00pm EST
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
Upcoming Earnings Alert:
Get ready for potential market movements as SenesTech Inc. SNES prepares to release earnings report on 28 Feb 2025.
Founded: | 2004 | Country: | United States |
Employees: | N/A | City: | PHOENIX |
Market Cap: | 2.3M | IPO Year: | 2016 |
Target Price: | $10.00 | AVG Volume (30 days): | 97.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -13.65 | EPS Growth: | N/A |
52 Week Low/High: | $1.90 - $9.80 | Next Earning Date: | 02-28-2025 |
Revenue: | $1,651,000 | Revenue Growth: | 38.16% |
Revenue Growth (this year): | 76.36% | Revenue Growth (next year): | 103.47% |
SNES Breaking Stock News: Dive into SNES Ticker-Specific Updates for Smart Investing
MT Newswires
5 days ago
PR Newswire
5 days ago
PR Newswire
13 days ago
PR Newswire
19 days ago
PR Newswire
a month ago
PR Newswire
a month ago
PR Newswire
a month ago
Simply Wall St.
3 months ago
The information presented on this page, "SNES SenesTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.